Linking oncogenesis and immune system evasion in acquired resistance to EGFR-targeting antibodies: Lessons from a preclinical model

Searching for biomarkers that associated with the acquired resistance of malignant cells to epidermal growth factor receptor (EGFR)-targeting monoclonal antibodies is crucial to improve the clinical benefits of these therapeutic agents. We have recently demonstrated that molecular alterations in bot...

Descripción completa

Detalles Bibliográficos
Autores principales: Garrido, Greta, Rabasa, Ailem, Sánchez, Belinda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912052/
https://www.ncbi.nlm.nih.gov/pubmed/24498560
http://dx.doi.org/10.4161/onci.26904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912052/
https://www.ncbi.nlm.nih.gov/pubmed/24498560
http://dx.doi.org/10.4161/onci.26904

Ejemplares similares